🔗 Permalink

Inventor profile of:

Stephen Thomas Davis

City:

Durham, North Carolina

Country:

United States

Published Applications:

Last publication date:

2015-11-05

Top Assignees for applications by Stephen Thomas Davis

The entities that hold a legal rights for patent applications filed by inventor Davis Stephen Thomas:

TRANSTECH PHARMA, INC. 7 High Point, NC United States
TransTech Pharma, LLC 3 High Point, NC United States
VTV THERAPEUTICS LLC 2 High Point, NC United States
SMITHKLINE BEECHAM CORPORATION 1 Philadelphia, PA United States
Trans Tech. Pharma. Inc. 1 High Point, NC United States
HIGH POINT PHARMACEUTICALS, LLC 1 High Point, NC United States

Recent patent applications by Davis Stephen Thomas

Stephen Thomas Davis from Durham, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2015-11-05

US20150313908A1

Human necessities

Combinations of a GLP1R Agonist and Metformin and Use Thereof for the Treatment of Type 2 Diabetes and Other Disorders

#2 | 2015-05-28

US20150148539A1

Chemistry; metallurgy

Substituted azoanthracene derivatives and intermediates for preparation thereof

#3 | 2015-03-26

US20150087640A1

Chemistry; metallurgy

Oxadiazoanthracene compounds for the treatment of diabetes

#4 | 2014-07-03

US20140187769A1

Chemistry; metallurgy

Oxadiazoanthracene compounds for the treatment of diabetes

#5 | 2013-11-28

US20130317015A1

Chemistry; metallurgy

Oxadiazoanthracene compounds for the treatment of diabetes

#6 | 2013-04-18

US20130096150A1

Chemistry; metallurgy

Substituted azoanthracene derivatives, pharmaceutical compositions, and methods of use thereof

#7 | 2011-06-30

US20110160198A1

Chemistry; metallurgy

Substituted azoanthracene derivatives, pharmaceutical compositions, and methods of use thereof

#8 | 2011-02-17

US20110039837A1

Chemistry; metallurgy

Oxadiazoanthracene compounds for the treatment of diabetes

#9 | 2010-12-23

US20100324033A1

Chemistry; metallurgy

Oxadiazoanthracene compounds for the treatment of diabetes

#10 | 2010-08-05

US20100197677A1

Chemistry; metallurgy

Oxadiazoanthracene compounds for the treatment of diabetes

#11 | 2009-12-10

US20090306063A1

Chemistry; metallurgy

Oxadiazoanthracene compounds for the treatment of diabetes

#12 | 2006-09-12

US9999331

Substituted oxindole derivatives as protein tyrosine and as protein serine/threonine kinase inhibitors and compositions and methods of treating chemotherapy and radiation therapy side effects

InventorID:

199033 ⎘